Tori Erxleben Rush, PharmD Selected to Return as PQA Panel Co-Chair in 2025

Tori-120x120

Tori Erxleben Rush, PharmD

Product Director, RxAnte

The Pharmacy Quality Alliance (PQA) has selected Tori Erxleben Rush, PharmD to return as co-chair for the Quality Measure Expert Panel (QMEP) for another year. Dr. Erxleben Rush will be continuing her second term on the QMEP and will remain on the panel until the end of 2027. As Director of clinical pharmacy programs, Dr. Erxleben Rush uses her expertise on measure performance to provide insight on recommended changes to quality measures as proposed by PQA. As co-chair, Erxleben Rush will present updates and facilitate discussions within the QMEP and help advance PQA’s mission to optimize health by advancing the quality of medication use.

PQA Quality Metrics Expert Panel (QMEP)
The QMEP is a select group of approximately 25 PQA members who assess measures in development and maintenance against standard measure criteria, make final recommendations to PQA membership regarding measure endorsement or retirement consideration, and make final recommendations to PQA staff for measure development discontinuation.
New QMEP members will serve a three-year term (2025-2027) with the option to serve a second term, and were chosen based on their measure development experience or other subject matter expertise (e.g., clinical, analytic, measurement science, quality improvement), as well as considerable experience participating in PQA groups.
The MUP and QMEP are standing PQA panels that meet monthly or, as needed, via webinar and will convene starting in January 2025.

Read more on PQA’s post about the appointed individuals serving on the panels: PQA Appoints Individuals to Serve on 2025 Panels

Related Resources

01-13-2026

RxAnte Announces Strategic Growth Investment from Primus Capital

01-12-2026

Impact of a Pharmacy Care Management Service on Cardiometabolic Medication Adherence and Resource Use for Medicare Advantage Beneficiaries

12-15-2025

Innovative Programs and Partnerships Yield Improved Pharmacy Quality and Patient Outcomes